Results
1 -
10 of
29Development and validation of a UPLC?MS/MS assay for the quantification of simotinib in human plasma, Analytical and Bioanalytical Chemistry Effect of the CYP2C19 genotype on the pharmacokinetics of icotinib in healthy male volunteers, European Journal of Clinical Pharmacology A phase II study of icotinib and whole-brain radiotherapy in Chinese patients with brain metastases from non-small cell lung cancer, Cancer Chemotherapy and Pharmacology Development of population pharmacokinetics model of icotinib with non-linear absorption characters in healthy Chinese volunteers to assess the CYP2C19 polymorphism and food-intake effect, European Journal of Clinical Pharmacology Clinical pharmacokinetics of Icotinib, an anti-cancer drug: evaluation of dose proportionality, food effect, and tolerability in healthy subjects, Cancer Chemotherapy and Pharmacology LCu2013MSu2013MS Quantitative Determination of Gefitinib in Human Serum and Cerebrospinal Fluid, Chromatographia Anti-N-methyl-d-aspartate receptor encephalitis with lung adenocarcinoma, Neurological Sciences Evaluation of 18F-labeled icotinib derivatives as potential PET agents for tumor imaging, Journal of Radioanalytical and Nuclear Chemistry Exon 19 deletion was associated with better survival outcomes in advanced lung adenocarcinoma with mutant EGFR treated with EGFR-TKIs as second-line therapy after first-line chemotherapy: a retrospective analysis of 128 patients, Clinical and Translational Oncology